Skip to main content
. Author manuscript; available in PMC: 2021 Mar 22.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2017 Sep 11;45(1):4–11. doi: 10.1007/s00259-017-3818-x

Fig. 4.

Fig. 4

18F-DCFBC PET/CT imaging demonstrating nodal involvement: 61-year-old male, with history of prostate cancer, Gleason 7, status postprostatectomy 2 years ago, with pre-scan PSA of 1.31 mg/mL. 18F–DCFBC fused PET/CT (top) and PET (bottom) images demonstrate two small 9 mm and 7 mm left paraaortic lymph nodes (arrows); biopsy confirmed tumor recurrence. Patient started treatment with enzalutamide.